ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $225,000 | +43.3% | 62,433 | 0.0% | 0.03% | +30.0% |
| Q4 2020 | $157,000 | 0.0% | 62,433 | 0.0% | 0.02% | -9.1% |
| Q3 2020 | $157,000 | -23.4% | 62,433 | 0.0% | 0.02% | -24.1% |
| Q2 2020 | $205,000 | +34.0% | 62,433 | 0.0% | 0.03% | +26.1% |
| Q1 2020 | $153,000 | -48.1% | 62,433 | 0.0% | 0.02% | -36.1% |
| Q4 2019 | $295,000 | +10.5% | 62,433 | 0.0% | 0.04% | 0.0% |
| Q3 2019 | $267,000 | -30.8% | 62,433 | 0.0% | 0.04% | -30.8% |
| Q2 2019 | $386,000 | +60.8% | 62,433 | 0.0% | 0.05% | +48.6% |
| Q1 2019 | $240,000 | +105.1% | 62,433 | 0.0% | 0.04% | +84.2% |
| Q4 2018 | $117,000 | -20.9% | 62,433 | 0.0% | 0.02% | -17.4% |
| Q3 2018 | $148,000 | -21.7% | 62,433 | 0.0% | 0.02% | -25.8% |
| Q2 2018 | $189,000 | -24.1% | 62,433 | -1.6% | 0.03% | -26.2% |
| Q1 2018 | $249,000 | -3.5% | 63,433 | +1.6% | 0.04% | -2.3% |
| Q4 2017 | $258,000 | -32.6% | 62,433 | 0.0% | 0.04% | -42.7% |
| Q3 2017 | $383,000 | -1.3% | 62,433 | 0.0% | 0.08% | -6.2% |
| Q2 2017 | $388,000 | -2.0% | 62,433 | 0.0% | 0.08% | 0.0% |
| Q1 2017 | $396,000 | +18.6% | 62,433 | 0.0% | 0.08% | +12.7% |
| Q4 2016 | $334,000 | -4.8% | 62,433 | 0.0% | 0.07% | -7.8% |
| Q3 2016 | $351,000 | +2.3% | 62,433 | 0.0% | 0.08% | 0.0% |
| Q2 2016 | $343,000 | -25.9% | 62,433 | 0.0% | 0.08% | -24.5% |
| Q1 2016 | $463,000 | -10.8% | 62,433 | 0.0% | 0.10% | -13.6% |
| Q4 2015 | $519,000 | -7.8% | 62,433 | 0.0% | 0.12% | -13.2% |
| Q3 2015 | $563,000 | -24.8% | 62,433 | 0.0% | 0.14% | -19.0% |
| Q2 2015 | $749,000 | -44.3% | 62,433 | -50.0% | 0.17% | +54.1% |
| Q1 2015 | $1,345,000 | +165.8% | 124,866 | +25.1% | 0.11% | -3.5% |
| Q4 2014 | $506,000 | +91.7% | 99,850 | 0.0% | 0.11% | +36.1% |
| Q3 2014 | $264,000 | -34.3% | 99,850 | 0.0% | 0.08% | -39.9% |
| Q2 2014 | $402,000 | -12.0% | 99,850 | 0.0% | 0.14% | -10.4% |
| Q1 2014 | $457,000 | +5.5% | 99,850 | 0.0% | 0.15% | +3.4% |
| Q4 2013 | $433,000 | +10.2% | 99,850 | 0.0% | 0.15% | -5.7% |
| Q3 2013 | $393,000 | +86.3% | 99,850 | 0.0% | 0.16% | +88.1% |
| Q2 2013 | $211,000 | – | 99,850 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |